Modification of the anticholinesterase action of 0,0-diethyl 0-(4-methylthio-M-tolyl) phosphorothioate (DMP) by drugs affecting hepatic microsomal enzymes.
D000818:Animals; D001580:Benzopyrenes / Q000494:pharmacology*; D001711:Biotransformation; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D003348:Cortisone / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000494:pharmacology; D004054:Diethylstilbestrol / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005001:Ethionine / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D008777:Methyltestosterone / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology*; D009552:Nikethamide / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology*; D051381:Rats; D013256:Steroids / Q000494:pharmacology*; D013739:Testosterone / Q000494:pharmacology
D001580:Benzopyrenes; D002800:Cholinesterase Inhibitors; D013256:Steroids; D009552:Nikethamide; D013739:Testosterone; D003900:Desoxycorticosterone; D011691:Puromycin; D011374:Progesterone; D004958:Estradiol; D004054:Diethylstilbestrol; D003348:Cortisone; D008777:Methyltestosterone; D005001:Ethionine; D010634:Phenobarbital